The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.
April 19th 2024
The current health care economy has driven many employers to self-funding models to offer affordable health care coverage to employees.
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed
View More
Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease
View More
B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence
View More
Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer
View More
Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago
View More
Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat
View More
Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?
View More
Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…
View More
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape
View More
The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
5 Questions... with Matthew Holt, Health 2.0 Conference Founder
Matthew Holt is a ubiquitous presence in the online world of Health 2.0. He is the proprietor of The Health Care Blog, essential reading that promises to tell you �everything you always wanted to know about the health care system.
4 Questions... with Doug Farrago, MD, of the Placebo Journal
Doug Farrago, MD, is a full-time practicing physician in Auburn, ME, and the founder of the Placebo Journal (www.placebojournal.com), which is meant to â��empower physicians with a skill that is sorely lacking â�" humor.â��
Eye on Innovation: The Nano-brain
Anirban Bandyopadhyay, PhD, artifi cial intelligence and molecular electronics scientist, National Institute for Materials Science at Tsukuba, Japan, talks about the "Nano-brain," a brain neuron-inspired, microscopic computer made up of 17 duroquinone molecules sitting in a ring pattern on a gold surface. The assembly has the potential to perform more than 4.3 billion commands at once, and could have far-reaching implications for medicine.
Personal Health Records: Just Say No
In the coming months, you will probably hear and read a lot about personal health records, as two technology heavyweights roll out initiatives designed to spur the mass consumerization of health information. The race between Google and Microsoft to apply the resources of the Internet to personalized healthcare might be great for consumers, but how will physicians benefit, if at all?
Sounding Board: A Personal Health Record Primer
With the field of PHRs now significantly expanding to include providers, payers, employers, and information technology industry giants, such as Microsoft and Google, public awareness and attitudes regarding PHRs have changed.
3D Mammography: Advances in Breast Cancer Screening
An improved mammography system currently in clinical trials at Emory Universitys Breast Imaging Center in Atlanta is showing dramatic improvements in both early detection of suspicious lesions and reductions in false-positive readings.
Last Writes: It's Nearly Spring... Time for Skiing!
Here in the Northeast, March is a month of anticipated change. After the short, cold, and dark days of February, March means still having some daylight left as we leave the office, the occasional spring tease of a mild day, and often the first signs of spring growth on the trees.
Nanomedicine Researchers Use Invisible Materials to 'Cloak' Implants
Nanomedicine researchers from UCLA and Northwestern University have teamed up to develop nanoscale polymer thin films that provide efficient localized drug delivery to cloak implants, rendering them invisible to the bodys immune system.
Science fiction stories about robots usually fall into one of two categories: good robots or bad robots. In the future, we are told, the machines will either be our obsequious servants, quietly following our orders according to an ingrained code of ethics, or our malevolent adversaries, hell-bent on eradicating humankind.